Why this grouping
Membership criteria
- HAS INHERITANCE
Typified by somatic mosaicism (HP:0001442).
Coverage and gaps
No exact MONDO mapping is declared, so MONDO descendant gaps are not inferred for this grouping.
| Status | DisMech entry | MONDO concept | In DisMech | Has MONDO ID | In grouping MONDO | Member state | Conditions satisfied | C1.1 Typified by somatic mosaicism (HP:0001442). |
|---|---|---|---|---|---|---|---|---|
| listed with MONDO ID |
CLOVES Syndrome
DISEASE
Differentiating mechanismObligate mosaic. Post-zygotic activating PIK3CA variants at 3-30% allele fraction in affected tissue from multiple embryonic lineages; the canonical PIK3CA-related overgrowth spectrum member.
PIK3CA hgnc:8975
|
CLOVES syndrome
MONDO:0013038
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Pacak-Zhuang syndrome
DISEASE
Differentiating mechanismObligate mosaic. Early post-zygotic gain-of-function EPAS1 (HIF2A) variants producing paragangliomas, somatostatinomas and polycythemia with no affected relatives.
EPAS1 hgnc:3374
|
Pacak-Zhuang syndrome
MONDO:0035540
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Paroxysmal Nocturnal Hemoglobinuria
DISEASE
Differentiating mechanismAcquired clonal mosaic of adult life. A somatic loss-of-function PIGA variant in a single haematopoietic stem cell expands under immune selection, leaving the patient a mosaic of GPI-deficient and normal blood cells.
PIGA hgnc:8957
|
Paroxysmal Nocturnal Hemoglobinuria
MONDO:0100244
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Proteus syndrome
DISEASE
Differentiating mechanismObligate mosaic. A post-zygotic AKT1 p.E17K activating variant confined to a subset of cells; mosaic lesion distribution and sporadic occurrence are diagnostic criteria, and germline transmission has never been observed.
AKT1 hgnc:391
|
Proteus syndrome
MONDO:0008318
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
SLC35A2-congenital disorder of glycosylation
DISEASE
Differentiating mechanismMosaic arm of a germline disorder. The MOGHE arm is a brain-restricted post-zygotic loss-of-function clone diagnosed on resected epileptogenic tissue, alongside the X-linked multisystem form.
SLC35A2 hgnc:11022
|
SLC35A2-congenital disorder of glycosylation
MONDO:0010478
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Sturge-Weber Syndrome
DISEASE
Differentiating mechanismObligate mosaic. A somatic GNAQ p.R183Q (rarely GNA11) activating variant at 1-18% allele fraction in affected tissue; the developmental timing of the event sets the extent from isolated port-wine stain to full leptomeningeal syndrome.
GNAQ hgnc:4390
|
Sturge-Weber syndrome
MONDO:0008501
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Tuberous Sclerosis Complex
DISEASE
Differentiating mechanismMosaic arm of a germline disorder. Most conventionally mutation-negative cases are low-level post-zygotic TSC1/TSC2 mosaics with milder phenotypes; the predominant mode is autosomal dominant.
|
Tuberous Sclerosis Complex
MONDO:0001734
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
VEXAS Syndrome
DISEASE
Differentiating mechanismAcquired clonal mosaic of adult life. Somatic UBA1 p.Met41 variants in haematopoietic stem cells, present in blood and marrow and absent from fibroblasts; the autoinflammatory member of the clonal-haematopoiesis pair.
UBA1 hgnc:12469
|
VEXAS syndrome
MONDO:0026777
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
angioosteohypertrophic syndrome
DISEASE
Differentiating mechanismObligate mosaic (Klippel-Trenaunay spectrum). Somatic PIK3CA activation confined to malformed lymphatic and venous tissue, with five recurrent hotspot variants accounting for most cases.
PIK3CA hgnc:8975
|
angioosteohypertrophic syndrome
MONDO:0007864
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Brain arteriovenous malformation
DISEASE
Differentiating mechanismSporadic lesions are somatic mosaic. Activating KRAS (or BRAF) variants in lesional endothelium and absent from paired blood; the germline AVMs of hereditary hemorrhagic telangiectasia are a distinct entity and not the basis of membership.
KRAS hgnc:6407
|
arteriovenous malformations of the brain
MONDO:0007154
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Blue Rubber Bleb Nevus Syndrome
DISEASE
Differentiating mechanismObligate mosaic with a double-hit architecture. Multifocal venous malformations arise from cis double somatic TEK (TIE2) mutations in an endothelial-lineage clone.
TEK hgnc:11724
|
blue rubber bleb nevus
MONDO:0007203
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Encephalocraniocutaneous Lipomatosis
DISEASE
Differentiating mechanismObligate mosaic. Post-zygotic activating FGFR1 (occasionally KRAS) variants distributed across neural-crest and mesenchymal derivatives.
FGFR1 hgnc:3688
|
encephalocraniocutaneous lipomatosis
MONDO:0013074
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Fibrous Dysplasia
DISEASE
Differentiating mechanismObligate mosaic. Early post-zygotic activating GNAS variants in skeletal progenitors; lesion burden tracks the mosaic distribution, and germline transmission has never been confirmed. McCune-Albright syndrome, the extraskeletal extension of the same clone, is a has_subtypes row on this entry and is covered through it.
GNAS hgnc:4392
|
fibrous dysplasia
MONDO:0000845
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Hemimegalencephaly
DISEASE
Differentiating mechanismObligate brain-restricted mosaic. De novo somatic gain-of-function variants in PIK3CA, AKT3, MTOR, RHEB or AKT1, or germline-plus-somatic two-hit loss of an mTOR repressor, arising in a neural progenitor and producing a mosaic variant gradient across one hemisphere.
|
hemimegalencephaly
MONDO:0020492
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Hyperinsulinemic Hypoglycemia
DISEASE
Differentiating mechanismMosaic arm of a germline disorder. Focal congenital hyperinsulinism requires a paternally inherited K-ATP channel variant plus somatic loss of the maternal 11p15 region within the islet lesion; the diffuse form is germline recessive.
|
hyperinsulinemic hypoglycemia
MONDO:0005803
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Hypothalamic Hamartoma with Gelastic Seizures
DISEASE
Differentiating mechanismObligate lesion-restricted mosaic. Somatic GLI3 loss-of-function or PRKACA variants confined to the hamartoma; the sporadic counterpart of the germline GLI3 Pallister-Hall syndrome.
GLI3 hgnc:4319
|
hypothalamic hamartomas with gelastic seizures
MONDO:0019484
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Focal Cortical Dysplasia Type II
DISEASE
Differentiating mechanismObligate brain-restricted mosaic mTORopathy. Somatic activator variants or two-hit repressor loss in as few as a thousand cortical neurons; the smallest-clone member of the grouping and the reason lesional tissue, not blood, is the diagnostic substrate.
|
isolated focal cortical dysplasia type II
MONDO:0011818
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Nevus of Ota
DISEASE
Differentiating mechanismObligate mosaic. Low-level post-zygotic GNAQ or GNA11 activation in dermal melanocytic tissue, undetectable in blood (GNA11 in a minority); the pigmentary sibling of the GNAQ vascular anomalies.
GNAQ hgnc:4390
|
nevus of Ota
MONDO:0016984
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
| listed with MONDO ID |
Porokeratosis
DISEASE
Differentiating mechanismMosaic arm of a germline disorder. A germline mevalonate-pathway variant is unmasked by a post-zygotic second hit, embryonic in linear porokeratosis and lesion-by-lesion in DSAP; localized forms can be purely somatic.
|
porokeratosis
MONDO:0006602
|
yes | yes | not assessed | listed | satisfied | SATISFIED |
Source
View YAML on GitHubRaw YAML
name: Somatic Mosaic Disorders
display_name: Somatic Mosaic Disorders (Post-zygotic Genetic Architecture)
creation_date: "2026-09-05T00:00:00Z"
description: >-
A curated union of dismech entries whose disease, or a recognized arm of it,
is caused by a variant that arose after fertilization and is therefore present
in some cells and absent from others. Membership is keyed on the mode of
inheritance itself: each member carries at least one curated inheritance block
bound to the HPO term Typified by somatic mosaicism (HP:0001442), attesting a
post-zygotic, DNA-level mosaic origin. This is a genetic-architecture grouping
assembled below the level of the classifications taxonomies; members otherwise
share nothing, spanning segmental overgrowth (AKT1, PIK3CA), malformations of
cortical development (PI3K-AKT-mTOR activators and repressors, SLC35A2),
vascular and pigmentary anomalies (GNAQ, GNA11, TEK, KRAS), skeletal dysplasia
(GNAS), endocrine tumours (EPAS1, GLI3, PRKACA), keratinization (mevalonate
pathway second hits), pancreatic islet lesions (11p15 loss), and acquired
clonal haematopoiesis (UBA1, PIGA). Mechanistic heterogeneity is the point,
not a defect: what the members have in common is that the causal lesion is a
clone, the disease distribution follows that clone, and the disorder is not
transmitted through the germline.
grouping_basis:
- OTHER
grouping_rationale: >-
Grouped on a shared non-Mendelian genetic architecture (post-zygotic somatic
mosaicism), not a shared mechanism, gene family, or phenotype, in the same way
Digenic and Oligogenic Disorders is grouped on multi-locus inheritance. The
grouping exists to make the mosaic architecture auditable and queryable: before
it was assembled, the flagship mosaic disorders encoded the same claim four
different ways (an HP:0001442 block, a block bound to Sporadic, a free-text
"Not applicable" block, or prose alone), so no query could recover the set.
The convention the members now follow is an inheritance block bound to
HP:0001442 with its own snippet-backed evidence, plus variant_origin SOMATIC
on the causal gene. Two tiers are admitted and each member's row says which:
disorders in which post-zygotic mosaicism is the mechanism (Proteus syndrome,
Sturge-Weber syndrome, fibrous dysplasia, VEXAS), and disorders with a
recognized, separately curated mosaic arm alongside a germline form (tuberous
sclerosis complex, porokeratosis, focal hyperinsulinism, the MOGHE arm of
SLC35A2 disease). Acquired clonal disorders of adult life (VEXAS, paroxysmal
nocturnal hemoglobinuria) are deliberately in scope: a somatic variant in one
haematopoietic stem cell that expands into a clone leaves the patient a
mosaic of mutant and normal blood cells, which is post-zygotic mosaicism by
the term's own definition, differing from the congenital members only in
timing and lineage. The criteria are NECESSARY, not NECESSARY_AND_SUFFICIENT,
because HP:0001442 is also bound in the knowledge base for two things that are
not somatic mosaic disorders in this sense: a single mosaic proband in an
otherwise germline dominant disorder (Neurodevelopmental Disorder with
Hypotonia and Speech Delay, an EIF4A2 case report) and parental germline
mosaicism explaining apparent sporadic recurrence (KCNH1 Associated Disorder).
Those entries correctly carry the term and are deliberately not members; a
qualifying non-member is therefore a lead to triage against the two tiers, not
an automatic addition. Functional mosaicism from X inactivation (CHILD
syndrome) is excluded outright and carries no HP:0001442 binding, since the
term names DNA-level post-zygotic mosaicism and the CHILD entry's own
inheritance block says that is not what it describes.
membership_criteria:
- description: >-
Every member has at least one curated inheritance block bound to Typified by
somatic mosaicism (HP:0001442), attesting that the disease, or a recognized
arm of it, arises from a post-zygotic variant confined to a clone of cells.
The criteria are NECESSARY only: carrying the term is required for
membership but does not by itself confer it, because the term is also used
for incidental mosaic probands and for parental germline mosaicism.
criteria_semantics: NECESSARY
logic:
criterion_predicate: HAS_INHERITANCE
description: Typified by somatic mosaicism (HP:0001442).
inheritance_term:
preferred_term: Somatic mosaicism
term:
id: HP:0001442
label: Typified by somatic mosaicism
members:
- member: Proteus syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic. A post-zygotic AKT1 p.E17K activating variant confined to a
subset of cells; mosaic lesion distribution and sporadic occurrence are
diagnostic criteria, and germline transmission has never been observed.
gene:
preferred_term: AKT1
term:
id: hgnc:391
label: AKT1
- member: CLOVES Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic. Post-zygotic activating PIK3CA variants at 3-30% allele
fraction in affected tissue from multiple embryonic lineages; the
canonical PIK3CA-related overgrowth spectrum member.
gene:
preferred_term: PIK3CA
term:
id: hgnc:8975
label: PIK3CA
- member: angioosteohypertrophic syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic (Klippel-Trenaunay spectrum). Somatic PIK3CA activation
confined to malformed lymphatic and venous tissue, with five recurrent
hotspot variants accounting for most cases.
gene:
preferred_term: PIK3CA
term:
id: hgnc:8975
label: PIK3CA
- member: Hemimegalencephaly
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate brain-restricted mosaic. De novo somatic gain-of-function
variants in PIK3CA, AKT3, MTOR, RHEB or AKT1, or germline-plus-somatic
two-hit loss of an mTOR repressor, arising in a neural progenitor and
producing a mosaic variant gradient across one hemisphere.
- member: Focal Cortical Dysplasia Type II
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate brain-restricted mosaic mTORopathy. Somatic activator variants or
two-hit repressor loss in as few as a thousand cortical neurons; the
smallest-clone member of the grouping and the reason lesional tissue, not
blood, is the diagnostic substrate.
- member: Hypothalamic Hamartoma with Gelastic Seizures
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate lesion-restricted mosaic. Somatic GLI3 loss-of-function or PRKACA
variants confined to the hamartoma; the sporadic counterpart of the
germline GLI3 Pallister-Hall syndrome.
gene:
preferred_term: GLI3
term:
id: hgnc:4319
label: GLI3
- member: Sturge-Weber Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic. A somatic GNAQ p.R183Q (rarely GNA11) activating variant
at 1-18% allele fraction in affected tissue; the developmental timing of
the event sets the extent from isolated port-wine stain to full
leptomeningeal syndrome.
gene:
preferred_term: GNAQ
term:
id: hgnc:4390
label: GNAQ
- member: Nevus of Ota
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic. Low-level post-zygotic GNAQ or GNA11 activation in dermal
melanocytic tissue, undetectable in blood (GNA11 in a minority); the pigmentary sibling of the
GNAQ vascular anomalies.
gene:
preferred_term: GNAQ
term:
id: hgnc:4390
label: GNAQ
- member: Blue Rubber Bleb Nevus Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic with a double-hit architecture. Multifocal venous
malformations arise from cis double somatic TEK (TIE2) mutations in an
endothelial-lineage clone.
gene:
preferred_term: TEK
term:
id: hgnc:11724
label: TEK
- member: Brain arteriovenous malformation
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Sporadic lesions are somatic mosaic. Activating KRAS (or BRAF) variants in
lesional endothelium and absent from paired blood; the germline AVMs of
hereditary hemorrhagic telangiectasia are a distinct entity and not the
basis of membership.
gene:
preferred_term: KRAS
term:
id: hgnc:6407
label: KRAS
- member: Encephalocraniocutaneous Lipomatosis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic. Post-zygotic activating FGFR1 (occasionally KRAS)
variants distributed across neural-crest and mesenchymal derivatives.
gene:
preferred_term: FGFR1
term:
id: hgnc:3688
label: FGFR1
- member: Fibrous Dysplasia
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic. Early post-zygotic activating GNAS variants in skeletal
progenitors; lesion burden tracks the mosaic distribution, and germline
transmission has never been confirmed. McCune-Albright syndrome, the
extraskeletal extension of the same clone, is a has_subtypes row on this
entry and is covered through it.
gene:
preferred_term: GNAS
term:
id: hgnc:4392
label: GNAS
- member: Pacak-Zhuang syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Obligate mosaic. Early post-zygotic gain-of-function EPAS1 (HIF2A)
variants producing paragangliomas, somatostatinomas and polycythemia with
no affected relatives.
gene:
preferred_term: EPAS1
term:
id: hgnc:3374
label: EPAS1
- member: VEXAS Syndrome
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Acquired clonal mosaic of adult life. Somatic UBA1 p.Met41 variants in
haematopoietic stem cells, present in blood and marrow and absent from
fibroblasts; the autoinflammatory member of the clonal-haematopoiesis pair.
gene:
preferred_term: UBA1
term:
id: hgnc:12469
label: UBA1
- member: Paroxysmal Nocturnal Hemoglobinuria
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Acquired clonal mosaic of adult life. A somatic loss-of-function PIGA
variant in a single haematopoietic stem cell expands under immune
selection, leaving the patient a mosaic of GPI-deficient and normal blood
cells.
gene:
preferred_term: PIGA
term:
id: hgnc:8957
label: PIGA
- member: Porokeratosis
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Mosaic arm of a germline disorder. A germline mevalonate-pathway variant is
unmasked by a post-zygotic second hit, embryonic in linear porokeratosis
and lesion-by-lesion in DSAP; localized forms can be purely somatic.
- member: Hyperinsulinemic Hypoglycemia
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Mosaic arm of a germline disorder. Focal congenital hyperinsulinism
requires a paternally inherited K-ATP channel variant plus somatic loss of
the maternal 11p15 region within the islet lesion; the diffuse form is
germline recessive.
- member: Tuberous Sclerosis Complex
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Mosaic arm of a germline disorder. Most conventionally mutation-negative
cases are low-level post-zygotic TSC1/TSC2 mosaics with milder phenotypes;
the predominant mode is autosomal dominant.
- member: SLC35A2-congenital disorder of glycosylation
member_type: DISEASE
differentiating_mechanisms:
- description: >-
Mosaic arm of a germline disorder. The MOGHE arm is a brain-restricted
post-zygotic loss-of-function clone diagnosed on resected epileptogenic
tissue, alongside the X-linked multisystem form.
gene:
preferred_term: SLC35A2
term:
id: hgnc:11022
label: SLC35A2
notes: >-
Candidates not yet bound and therefore not listed: Schnitzler syndrome
(myeloid-lineage NLRP3 mosaicism in a
minority), CINCA/NOMID (mosaic NLRP3 in mutation-negative cases), congenital
melanocytic nevus (NRAS), craniofacial microsomia, and clonal haematopoiesis
of indeterminate potential, which has no entry. Isolated mosaic aneuploidies
(mosaic Turner or trisomy) are chromosomal-segregation mosaics and were not
assessed for this grouping. Mosaic Variegated Aneuploidy Syndrome is
deliberately absent: it is autosomal recessive, and its mosaicism is a
downstream phenotype of germline BUB1B loss rather than a post-zygotic causal
variant.